Tackling Mpox Situation in India – A Need for Global Surveillance

Tackling Mpox Situation in India

Abstract

The recent rise of cases of Mpox (monkeypox) is a reason for great adversity and a challenging situation for public health globally. Mpox has been spreading in African countries since 2022. Earlier in the year 2022, the WHO had declared a Public Health Emergency of International Concern (PHEIC) for the outbreak of Mpox. According to WHO, since 2022, there have been 99,176 Mpox cases and 208 deaths reported globally from 116 countries, and the number of cases and deaths has increased significantly in 2024 so far, with over 15,600 cases and 537 deaths reported. In India, to date, a total of 32 cases of Mpox have been detected, with a death occurring in Kerala in March 2024. The Indian government is very vigilant and is taking necessary measures. However, the commentary argues that the fight against Mpox cannot be confined to national borders. The nature of infectious disease threats necessitates international collaboration to strengthen disease surveillance, share data, and develop new vaccines and treatments. Strengthening the infrastructure by investing in the healthcare systems for quick response to outbreaks and disease control, increasing the healthcare workforce, and enhancing the logistics and supply chain in developing the emergency response. Preventive measures, including vaccination and international collaborations, should be prioritized globally.